Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-01

Clinical Trial Update: Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating the efficacy and safety of Andrographolide Sulfonate in patients with acute tonsillitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Andrographolide Sulfonate (andrographolide sulfonate)

Snippet

Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Conditions: Acute Tonsillitis | Phase 4 | Status: UNKNOWN